New advances in cancer research to be highlighted at University of LeicesterApril 22, 2009Public event on Tuesday, April 28 A scientist whose work is key to understanding how cancer cells divide and spread in the body is to present advances in his latest research at a public forum to be held at the University of Leicester. Professor Andrew Fry, of the Department of Biochemistry, leads a renowned research group at the University of Leicester that is internationally consulted as a leading laboratory in the field of Molecular Cell Biology. Many current cancer treatments act by killing all dividing cells and are not necessarily specific for the cancer cells, hence the severe side effects. One of Professor Fry's aims is to understand the molecular control of cell division and as a result identify proteins which can be targeted in specific tumours, leaving other cells unharmed. On Tuesday April 28, Professor Fry will discuss his research and its future direction. The lecture, How Cells Control the Great Divide, in the Ken Edwards Building Lecture Theatre 1, starts at 5.30pm. It is open to the public and free. Professor Fry said: "In my presentation, I will highlight how our research has contributed to the understanding of a key aspect of human cell biology that is cell division. This research has provided important new insights on the causes of many human diseases, including cancer, and led to the identification of a number of new targets for cancer treatment. "An adult human being contains millions of cells that all arise following the fertilization of an egg cell by a sperm cell. Human development therefore requires cells to divide again and again to create the tissues and organs of our body. Cell division is a complex mechanical process that not only leads to the production of new cells but ensures that each one maintains the right genetic content required to sustain life. Loss of control over cell proliferation and the development of genetic and chromosomal abnormalities are classic hallmarks of cancer." Professor Fry added that the group's research falls into three broad areas: * Study of a family of proteins that play a role in cell division and cilia organization which makes them attractive targets for the development of new anti-cancer drugs * Research on a particular structure that lies at the heart of each and every cell, called the centrosome (standing for "central body"), and how centrosome defects contribute to cancer progression * Examination of the cell biological basis of ciliopathy disorders, a diverse set of devastating human diseases with symptoms ranging from polycystic kidney disease to mental retardation, obesity and progressive blindness. "Something that has helped us to establish a world-class reputation is a state-of-the-art Microscopy facility at the University of Leicester. The ability to use high resolution microscopy, to see what is actually going on in cells, is critical to research. So having this facility at Leicester allows us to compete at world level." University of Leicester |
|||||||||||||||||||||
| Related Cancer Research Current Events and Cancer Research News Articles Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Gene mismatch influences success of bone marrow transplants A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics. Common pain relief medication may encourage cancer growth Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning. 'Cross-talk' mechanism contributes to colorectal cancer Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors. No-entry zones for AIDS virus The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs. Quarter of a million children in England at risk of skin cancer from sunbeds An estimated quarter of a million 11-17 year olds in England are being put at increased risk of developing malignant melanoma by using sunbeds, warn researchers in a letter to this week's BMJ. Iowa State University researcher discovers key to vital DNA, protein interaction A researcher at Iowa State University has discovered how a group of proteins from plant pathogenic bacteria interact with DNA in the plant cell, opening up the possibility for what the scientist calls a "cascade of advances." New mechanism explains how the body prevents formation of blood vessels Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels. Newly Discovered Fat Molecule: An Undersea Killer with an Upside A chemical culprit responsible for the rapid, mysterious death of phytoplankton in the North Atlantic Ocean has been found by collaborating scientists at Rutgers University and the Woods Hole Oceanographic Institution (WHOI). This same chemical may hold unexpected promise in cancer research. More Cancer Research Current Events and Cancer Research News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||